Health-Related Quality of Life Following Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer
Vaibhav Sharma et al. | RSS | 2024
Acute Toxicity Following PSMA-Directed Focal Salvage Robotic SBRT for Local Recurrences Following Prior Robotic Prostate SBRT
Zachary Wilson et al | RSS | 2024
Intensity-modulated Radiotherapy and Cisplatin-based Chemotherapy for Anal Cancer: Long-term Outcomes at a Single Institution
Gerardi MA, Zerella MA, Bergamaschi L, Ferrari A, Arculeo S, Bagnardi V, Frassoni S, Petz W, Fodor C, Emiro F, Cattani F, Leonardi MC, Zampino MG, Jereczek-Fossa BA | Int J Colorectal Dis | 2023
Moderately Hypofractionated Helical TomoTherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
Cozzi S, Ruggieri MP, Alì E, Ghersi SF, Vigo F, Augugliaro M, Giaccherini L, Iori F, Najafi M, Bardoscia L, Botti A, Trojani V, Ciammella P, Iotti C | In Vivo | 2023
Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits
Gao J, Xu B, Lin Y, Xu Z, Huang M, Li X, Wu X, Chen Y. | Cancers (Basel) | 2022
Salvage Stereotactic Reirradiation for Intraprostatic Cancer Recurrence: A Large Retrospective Study
Allali S, Loap P, Bibault JE, Krepps S, Deforge A, Moreau D, Durdux C, Giraud P | Prostate | 2023
Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultra-hypofractionated Stereotactic Body Radiotherapy
Piotr Milecki, Anna Adamska, Anna Rucinska, Grzegorz Pałucki, Agnieszka Szumiło, Agnieszka Skrobała, Agata Jodda, Michał Michalak | J Pers Med | 2023
Stereotactic Body Radiation Therapy for Prostate Cancer: A Study Comparing 3-year Genitourinary Toxicity Between CyberKnife and Volumetric-Modulated Arc Therapy by Propensity Score Analysis
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki | Radiat Oncol | 2023
Robotic Stereotactic Body Radiotherapy for Localized Prostate Cancer: Final Analysis of the German Hypostat Trial
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck | Strahlenther Onkol | 2023
5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated (LBA 03)
N. van As, A. Tree, J. Patel, P. Ostler, H. Van Der Voet, D. A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, J. G. Armstrong, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, G. Manning, S. Brown, C. Griffin, and E. Hall | ASTRO | 2023
Multifocal MRI-Directed Simultaneous Integrated Boost (SIB) in the Treatment of Prostate Cancer with Stereotactic Body Radiation Therapy (SBRT) (2866)
J. C. Hurwitz, V. Santos, M. Akerman, C. Mendez, A. Sanchez, A. Corcoran, A. Katz, H. Lepor, S. Taneja, T. J. Carpenter, A. J. Evans, A. Mahadevan, J. A. Haas, and J. W. Lischalk | ASTRO | 2023
Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results (2913)
C. Mendez, J. W. Lischalk, A. Katz, T. J. Carpenter, M. R. Witten, A. Sanchez, V. Santos, A. Corcoran, E. Awad, I. Trivedi, S. R. Blacksburg, and J. Haas | ASTRO | 2023
Hypo-fractionated Radiotherapy with SpaceOAR for Prostate Cancer Treated with Radixact TomoTherapy
Sumeyra Can, Didem Karaçetin, Hamza Tatlı, Özge Atilla, Nilgül Nalbant | PO-1818 | ESTRO | 2023
Dosimetric Comparison of VMAT, Fixed-field IMRT and Helical TomoTherapy for Prostate Plans using the MADD Metric
Noelia Suarez Alvarez, Albert Bartrés Salido, Vicent Pastor i SanchÃs, Nam Nguyen, Vincent Vinh-Hung, Melanie Erzilbengoa | PO-1800 | ESTRO | 2023
Salvage stereotactic body radiotherapy in oligometastatic gynaecological cancer
Martina Midulla, Andrei Fodor, Flavia Zerbetto, Chiara Lucrezia Deantoni, Roberta Tummineri, Laura Giannini, Sara Broggi, Miriam Torrisi, Federica Ferrario, Chiara Chissotti, Stefano Lorenzo Villa, Paola Mangili, Claudio Fiorino, Stefano Arcangeli, Nadia Gisella Di Muzio | PD-0813 | ESTRO | 2023
Impact of the VOLO Optimizer on Treatment Plan Quality of Stereotactic Prostate Radiotherapy
T. Viren, J. Seppälä | PO-2052 | ESTRO | 2023
Stereotactic Radiotherapy of Prostate Cancer Patients – Two Techniques Comparison: Preliminary Results
Aleksandra Napieralska, Wojciech Majewski, Marcela Krzempek, Grzegorz Woźniak, Marcin Miszczyk, Małgorzata Kraszkiewicz, Agnieszka Namysł-Kaletka | PO-2047 | ESTRO | 2023
Stereotactic Salvage Radiotherapy for Prostate Bed Relapse, Early Analysis from a Prospective Trial
Giulio Francolini, Luca Burchini, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Giulio Frosini, Barbara Guerrieri, Michele Ganovelli, Andrea Allegra, Viola Salvestrini, Luca Visani, Emanuela Olmetto, Carlotta Becherini, Gabriele Simontacchi, Manuele Roghi, Maria Grazia Carnevale, Isacco Desideri, Icro Meattini, Lorenzo Livi | PO-1459 | ESTRO | 2023
Stereotactic Focused Radiotherapy for Low-risk Prostate Cancer: Results of a Phase-II Trial
Paul Nguyen, Bertrand Donneaux, Céline Louis, Szusa Bodgal, Sven Philippi, Bérangère Frédérick, Sylvie Biver, Ludovic Harzé, Yves Lasar, Guillaume Vogin, Philippe Nickers | PO-1458 | ESTRO | 2023
Stereotactic Reirradiation for Locally Recurrent Prostate Cancer after Definitive Radiotherapy
Giulio Francolini et al | PD-0576 | ESTRO | 2023